Zydus Lifesciences will roll out generic semaglutide injections in India post-patent expiry, using a reusable single-pen ...

India’s market for anti-obesity medicines is expected to undergo a significant shift in 2026, with prices of leading ...

A new pill could help patients lose more weight and gain better control of their blood sugar levels than current weight loss ...

Daily orforglipron tablets led to greater weight loss than semaglutide tablets, offering potential oral alternative to Wegovy and Mounjaro ...

Experts have hailed a powerful new weapon in the fight against Type 2 diabetes – a simple daily pill that can help people shed pounds and bring their blood sugar levels under control. Orfroglipron, ...

A NEW weight loss pill that’s twice as effective as ones on the market also slashes the risk of type 2 diabetes, scientists say. But the tablet – called orforglipron – also ...

Ahmedabad: Zydus Lifesciences Limited said it plans to launch semaglutide injection in India under the brand names Semaglyn, Mashema and Alterme after.

Zydus Lifesciences Limited, an innovation-led life-sciences company with an international presence, plans to launch Semaglutide Injection under the brand names - SEMAGLYN™, MASHEMA™ and ALTERME™, upon ...

The first daily GLP-1 pill for weight loss, oral semaglutide, marketed as Wegovy, was launched in the US last year, expanding access to obesity treatment beyond injections.

Insulet Stock: why GLP-1 fears are overblown, with growth driven by Europe/MENA expansion. Read here for a detailed analysis on PODD stock.

As weight-loss injections like Ozempic and Mounjaro continue to gain global popularity, a new study has suggested that metabolic and bariatric surgery may provide stronger and more sustained ...